Shaping the future of pathology

We deliver high‑quality laboratory and diagnostic services, performing more than 65 million tests every year. With a portfolio of over 6,000 assays, our accredited labs provide everything from routine blood tests to advanced molecular and genetic analysis – giving you fast, reliable answers when they matter most.

Our NHS Partnerships

History icon

Test database

Our database hosts almost 2,000 diagnostic tests. Use our user-friendly search feature for full user details including how to order tests, collect samples, and interpret results.

Research & Innovation

Positive Difference icon

£0m+ invested in

employee-led innovation and research projects since 2022

Droplet magnified icon

1st urban drone deliveries

of pathology samples in the UK

Chromosome icon

0 hospital sites

supported to roll out Rapid Pathogen Metagenomics

News icon

News & resources

Molly Rutherford presents her poster at the ISBT conference

Synnovis supports development to dramatically reduce pre-transfusion testing times for myeloma patients

Validation work undertaken by Synnovis Biomedical Scientist, Molly Rutherford, has the potential to significantly improve the blood transfusion experience for patients receiving daratumumab, a treatment widely used for multiple myeloma. Multiple myeloma is the second most common blood cancer worldwide. Although it remains incurable, major advances in treatment have significantly improved patient outcomes, particularly following [...]

World Hepatitis Day initiative aims to detect undiagnosed blood borne viruses across South East London

To mark World Hepatitis Day on 28 July, Synnovis and NHS Trust colleagues in South East London are expanding routine blood testing in a one-day initiative to include screening for blood borne viruses, helping more people access early diagnosis and care. There are nearly two million new cases of hepatitis B and C each year. [...]

Life-saving genetic test for every baby in England rolls out from October 2026

The rapid digital PCR test for Spinal Muscular Atrophy (SMA) developed by Synnovis* is a first for England SYNLAB is delighted to recognise the Synnovis Monogenics team, based at Guy’s Hospital in London, for their contribution to making the addition of Spinal Muscular Atrophy (SMA) testing to England’s newborn screening programme possible. Our team developed [...]